Option delistings effective October 26th include BIOCEPT INC (BIOC). Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on
Option delistings effective October 26th include BIOCEPT INC (BIOC). Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on
In a regulatory filing, Biocept disclosed that after considering strategic alternatives, the company filed a voluntary petition for relief under the provisions of Chapter 7 of Title 11 of the
Maxim Group analyst Jason McCarthy maintained a Hold rating on Biocept (BIOC – Research Report) yesterday. The company’s shares opened today at $1.39. According to TipRanks, McCarthy is an analyst
Biocept announced the full enrollment of 40 subjects with breast or non-small cell lung cancer, or NSCLC, who have suspicious or confirmed leptomeningeal metastases, or LM, in the feasibility phase
Shares of molecular diagnostics company Biocept (NASDAQ:BIOC) have skyrocketed by nearly 77% today after it entered into a non-exclusive licensing deal with Plus Therapeutics (NASDAQ:PSTV) for CNSide, Biocept’s cerebrospinal fluid-based